Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn
About

News

Top 10 articles of last week

Lex Hall  |  23 Apr 2019Text size  Decrease  Increase  |  
Email to Friend

Topping coverage this week was news that SMSFs face further cuts in addition to franking reforms, followed by a look at three alternative ideas if Labor's plan takes effect, and a survey of 'exponential' growth sectors.

Forget franking, SMSFs face even more cuts

Labor's plan to axe cash refunds for excess franking credits may have monopolised attention in the countdown to the election but investors stand to lose out even more from other proposals, Australia's peak superannuation body warns. 

Franking debate: 3 alternative ideas worth considering

The setting of the federal election date brings into sharper focus the franking debate. David Ellis suggests some alternative ideas to consider if Labor's plan is implemented. 

9 undervalued companies with 'exponential' growth potential pt. 2

Energy & Environmental Systems; Medicine & Neuroscience; and Robotics: In part two of our series, we examine the changes taking place in these areas and identify the most undervalued leader in each field. 

8 top investing tips

Sticking to what you know, keeping a written plan and tuning out unnecessary market commentary are among these top investing tips from Ben Johnson, director of passive strategies, Morningstar US. 

Investing basics: raising a portfolio you don't have to babysit

How to build an ultra-low maintenance, hands-free portfolio to help you reach your financial goals. 

Franking credit changes unlikely to hurt share prices

Labor's plan to scrap cash payments for excess franking credits is unlikely to dent share prices if the proposal becomes law in July, according to one Aussie fund manager. 

Choosing a US market ETF: IVV or VTS

iShares S&P 500 ETF (IVV) and Vanguard US Total Market Shares Index ETF (VTS) are almost indistinguishable. They're both cheap and track the broad US stock market. 

Pot stocks tipped to grow but regulation still a drag

Medicinal cannabis is being seen as an alternative to opioid drugs in the treatment of pain relief, and the global market is tipped to be worth more than $200bn by the end of 2025. 

Invest like the Future Fund

Australia's sovereign wealth fund has returned an impressive 8.5 per cent a year over the last decade, against a target annual benchmark return of 6.7 per cent. 

Is the boom back for bonds?

As rate cuts loom, bond investors are being urged to stick to quality and stay diversified, writes Anthony Fensom. 

is content editor for Morningstar Australia

© 2020 Morningstar, Inc. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. This information is to be used for personal, non-commercial purposes only. No reproduction is permitted without the prior written consent of Morningstar. Any general advice or 'class service' have been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), or its Authorised Representatives, and/or Morningstar Research Ltd, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/s/fsg.pdf. Our publications, ratings and products should be viewed as an additional investment resource, not as your sole source of information. Past performance does not necessarily indicate a financial product's future performance. To obtain advice tailored to your situation, contact a licensed financial adviser. Some material is copyright and published under licence from ASX Operations Pty Ltd ACN 004 523 782. The article is current as at date of publication.

Email To Friend